Author
Thermo Fisher Scientific
Thermo Fisher Scientific
A unique company dedicated to serving science helping our customers drive productivity and accelerate results. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.
Tags
Article
Health
LinkedIn Logo

Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs)

Tu, 26.8.2025
| Original article from: Thermo Fisher Scientific / Aaron Lamb
Nitrosamine drug substance-related impurities (NDSRIs) pose major risks in pharmaceuticals. Learn about their sources, regulations, and detection methods for drug safety.
<p><strong>Thermo Fisher Scientific: </strong>Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs)</p>

Thermo Fisher Scientific: Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs)

Nitrosamine drug substance-related impurities (NDSRIs) have emerged as a significant concern in the pharmaceutical industry. These impurities are associated with potential carcinogenic risks, making their detection and control crucial for ensuring drug safety and efficacy. This blog aims to provide an in-depth understanding of NDSRIs, their sources, regulatory guidelines, and methods for their detection and control.

Thermo Fisher Scientific: Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs).Thermo Fisher Scientific: Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs).

What are Nitrosamines?

Nitrosamines are chemical compounds containing the nitroso functional group. While some nitrosamines are formed naturally and can be found in foods, beverages, and the environment, others can be synthetically produced. The concern arises from the fact that many nitrosamines have been identified as carcinogenic in animal studies, with implications for human health.

Sources of NDSRI in pharmaceuticals

NDSRI can form during the manufacturing process of pharmaceuticals through various pathways, including:

  1. Reaction of secondary or tertiary amines with nitrosating agents: Secondary or tertiary amines present in drug substances or excipients can react with nitrosating agents such as nitrites, leading to the formation of NDSRIs.
  2. Degradation pathways: Some drug substances may degrade over time, leading to the formation of NDSRIs.
  3. Contaminated raw materials: Raw materials contaminated with NDSRIs or nitrosating agents can introduce these impurities into the final product.
  4. Cross-contamination: Cross-contamination during manufacturing processes can also lead to the presence of NDSRIs in drug products.

Regulatory guidelines

Regulatory agencies like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and others have issued guidelines to control and limit the presence of NDSRIs in drug products. Key points include:

  1. Risk assessment: Manufacturers must conduct a thorough risk assessment to identify potential sources of NDSRIs.
  2. Analytical testing: Use of validated analytical methods to detect and quantify NDSRIs in drug products.
  3. Control strategies: Implementation of control strategies to mitigate the formation of NDSRIs during manufacturing.
  4. Acceptable Intake (AI) limits: Adherence to specified acceptable intake limits for NDSRIs to ensure patient safety. This is a challenge for NDSRIs as specific toxicology information is often missing so establishing AIs is a problem.

Detection and analysis

Detecting and analyzing NDSRIs requires sophisticated analytical techniques. The most used methods include:

  1. Gas Chromatography-Mass Spectrometry (GC-MS): GC-MS is highly effective for separating and identifying volatile nitrosamines.
  2. Liquid Chromatography-Mass Spectrometry (LC-MS): LC-MS is suitable for non-volatile nitrosamines and provides high sensitivity and specificity.
  3. High-Performance Liquid Chromatography (HPLC): HPLC can be used in combination with other detectors for the analysis of nitrosamines.
  4. Ion Chromatography: Useful for detecting nitrite and nitrate ions, which are precursors to nitrosamine formation.

Control and mitigation strategies

To control and mitigate the formation of NDSRIs, manufacturers can implement several strategies:

  1. Process optimization: Optimizing manufacturing processes to minimize the use of nitrosating agents and amines. This is also a challenge as many APIs contain secondary and tertiary amine functionality.
  2. Raw material quality control: Ensuring raw materials are free from NDSRIs.
  3. Environmental controls: Implementing environmental controls to prevent cross-contamination.
  4. Stability studies: Conducting stability studies to understand the degradation pathways and potential for NDSRIs formation.
  5. Formulation adjustments: Adjusting formulations to replace or reduce the use of amines or nitrosating agents.

Conclusion

NDSRIs present a significant challenge for the pharmaceutical industry, with implications for drug safety and regulatory compliance. By understanding the sources of NDSRIs, adhering to regulatory guidelines, and employing robust analytical and control strategies, manufacturers can effectively manage these impurities and ensure the safety and efficacy of their drug products. Continuous vigilance and advancements in analytical technology will be crucial in addressing the evolving landscape of nitrosamine impurities.

Aaron Lamb

Vertical Marketing Manager, Pharma and Biopharma, Thermo Fisher Scientific

Thermo Fisher Scientific
LinkedIn Logo
 

Related content

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
 

Related articles

Nitrosamines and Impurities Resource Hub
Article | Webinars

Nitrosamines and Impurities Resource Hub

Over four years ago, the nitrosamine crisis shook the pharmaceutical world, and it still remains a hot topic. Since then, more stringent regulations have been put in place.
Waters Corporation (Europe)
tag
share
more
Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety
Scientific article | Science and research

Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety

The study presents a validated LC-MS/MS method for rapid and accurate quantification of four nitrosamine impurities in Risperidone, supporting enhanced impurity monitoring and quality control.
LabRulez
tag
share
more
A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops
Scientific article | Science and research

A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops

A rapid, green LC-QqQ-MS/MS method quantifies N-MOX and DNPP in moxifloxacin tablets and eye drops. Validated per ICH, it ensures safety by detecting trace NDSRIs with minimal environmental impact.
LabRulez
tag
share
more
News from LabRulezLCMS Library - Week 35, 2025
Article | Application

News from LabRulezLCMS Library - Week 35, 2025

This week we bring you poster by Agilent Technologies/ASMS, brochure by Shimadzu, other document by Thermo Fisher Scientific and application note by Waters Corporation!
LabRulez
tag
share
more
 

Related content

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
 

Related articles

Nitrosamines and Impurities Resource Hub
Article | Webinars

Nitrosamines and Impurities Resource Hub

Over four years ago, the nitrosamine crisis shook the pharmaceutical world, and it still remains a hot topic. Since then, more stringent regulations have been put in place.
Waters Corporation (Europe)
tag
share
more
Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety
Scientific article | Science and research

Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety

The study presents a validated LC-MS/MS method for rapid and accurate quantification of four nitrosamine impurities in Risperidone, supporting enhanced impurity monitoring and quality control.
LabRulez
tag
share
more
A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops
Scientific article | Science and research

A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops

A rapid, green LC-QqQ-MS/MS method quantifies N-MOX and DNPP in moxifloxacin tablets and eye drops. Validated per ICH, it ensures safety by detecting trace NDSRIs with minimal environmental impact.
LabRulez
tag
share
more
News from LabRulezLCMS Library - Week 35, 2025
Article | Application

News from LabRulezLCMS Library - Week 35, 2025

This week we bring you poster by Agilent Technologies/ASMS, brochure by Shimadzu, other document by Thermo Fisher Scientific and application note by Waters Corporation!
LabRulez
tag
share
more
 

Related content

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
 

Related articles

Nitrosamines and Impurities Resource Hub
Article | Webinars

Nitrosamines and Impurities Resource Hub

Over four years ago, the nitrosamine crisis shook the pharmaceutical world, and it still remains a hot topic. Since then, more stringent regulations have been put in place.
Waters Corporation (Europe)
tag
share
more
Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety
Scientific article | Science and research

Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety

The study presents a validated LC-MS/MS method for rapid and accurate quantification of four nitrosamine impurities in Risperidone, supporting enhanced impurity monitoring and quality control.
LabRulez
tag
share
more
A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops
Scientific article | Science and research

A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops

A rapid, green LC-QqQ-MS/MS method quantifies N-MOX and DNPP in moxifloxacin tablets and eye drops. Validated per ICH, it ensures safety by detecting trace NDSRIs with minimal environmental impact.
LabRulez
tag
share
more
News from LabRulezLCMS Library - Week 35, 2025
Article | Application

News from LabRulezLCMS Library - Week 35, 2025

This week we bring you poster by Agilent Technologies/ASMS, brochure by Shimadzu, other document by Thermo Fisher Scientific and application note by Waters Corporation!
LabRulez
tag
share
more
 

Related content

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
 

Related articles

Nitrosamines and Impurities Resource Hub
Article | Webinars

Nitrosamines and Impurities Resource Hub

Over four years ago, the nitrosamine crisis shook the pharmaceutical world, and it still remains a hot topic. Since then, more stringent regulations have been put in place.
Waters Corporation (Europe)
tag
share
more
Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety
Scientific article | Science and research

Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety

The study presents a validated LC-MS/MS method for rapid and accurate quantification of four nitrosamine impurities in Risperidone, supporting enhanced impurity monitoring and quality control.
LabRulez
tag
share
more
A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops
Scientific article | Science and research

A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops

A rapid, green LC-QqQ-MS/MS method quantifies N-MOX and DNPP in moxifloxacin tablets and eye drops. Validated per ICH, it ensures safety by detecting trace NDSRIs with minimal environmental impact.
LabRulez
tag
share
more
News from LabRulezLCMS Library - Week 35, 2025
Article | Application

News from LabRulezLCMS Library - Week 35, 2025

This week we bring you poster by Agilent Technologies/ASMS, brochure by Shimadzu, other document by Thermo Fisher Scientific and application note by Waters Corporation!
LabRulez
tag
share
more
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike